News
The latest news from HCCI

For general media inquiries or to propose collaborative projects, please contact us

Sep
12

Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin Products

We previously published two blogs discussing trends in out-of-pocket spending on insulin products. First , we presented data illustrating how average monthly out-of-pocket spending in 2017 varied considerably by month, particularly for individuals enrolled in consumer-directed health plans (CDHPs) that carry higher deductibles. Second , we examined the relationship between increasing point-of-sale...
Continue reading
Sep
12

Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in January

Earlier this week we presented data on out-of-pocket spending on insulin during each month in 2017. In that blog, we showed that enrollees in employer-sponsored health insurance paid more out-of-pocket for insulin products at the beginning of the calendar year. We examined the relationship between increasing point-of-sale prices for insulin and higher out-of-pocket spending in January for a subset...
Continue reading
Sep
10

Out-of-Pocket Spending on Insulin is Highest at the Beginning of the Year

People who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every month throughout the calendar year, likely as enrollees met their annual deductible...
Continue reading
May
31

HCCI will be presenting at AcademyHealth's 2019 Annual Research Meeting

The Health Care Cost Institute (HCCI) is proud to present five posters at the AcademyHealth 2019 Annual Research Meeting in Washington, D.C. These posters, which cover HCCI research on a wide variety of topics, focus on health care spending and utilization trends among the commercially insured population. If you are attending the conference, please check out the schedule below to meet our staff an...
Continue reading
Apr
03

The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

HCCI's research on rising insulin list prices was recently cited by The New York Times in its reporting on Express Scripts' new plan to offer a $25 cap for month insulin. From the article: "Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced on Wednesday. The move is aimed at addressing rising an...
Continue reading
Feb
05

HCCI Research Used in Support of Congressional Inquiries

HCCI's recent report on rising insulin prices was cited in support of congressional  inquiries into drug pricing. This included a letter from U.S. Senator Tim Kaine (D-VA) to executives at Eli Lilly, Novo Nordisk, and Sanofi requesting information on insulin pricing.  Additionally, HCCI's research on emergency care was cited in a letter from U.S. Senators Bill Cassidy (R-LA)&nb...
Continue reading
Jan
28

HCCI Insulin Report Receives Extensive Media Coverage

 HCCI's recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC , CBS , CNN , The New York Times , The Hill , U.S. News & World Report , and USA Today .  From CNN: "Congress and the Trump administration continue to push for a drug pricing plan and were given more ammunition Tuesday in the form of a report docu...
Continue reading
Jan
22

Reuters: U.S. Insulin Costs Per Patient Nearly Doubled From 2012 to 2016: Study

​HCCI's latest research on rising insulin prices was recently featured in Reuters. HCCI's report detailed both use and price trends of insulin used by those with type 1 diabetes from 2012 to 2016. Per Reuters article: "A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that at $2,864 per patient in 2012, according to a...
Continue reading
Jan
21

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices

We used health care claims data to investigate trends in total health care spending on individuals with type 1 diabetes between 2012 and 2016. We found a rapid increase in total health care spending, driven primarily by gross spending on insulin that doubled over the period. During that time insulin use rose only modestly. While the composition of insulins used shifted, the price of all types of i...
Continue reading
Nov
29

Price of insulin prescription doubled between 2012 and 2016

In honor of National Diabetes Month, our inaugural blog post focuses on a topic of particular interest to people with diabetes: the price of insulin. Insulin is the hormone responsible for the body's ability to use sugar and prevent dangerously high and potentially deadly levels of blood sugar. Diabetics are unable to make enough insulin to support their bodies' needs, and thus many are dependent ...
Continue reading